BCOS

This will inform future discussions and funding applications for collaborative UK cardio-oncology research. For further information, please contact enquiries@bhfcrc.org.

Please take 10 minutes to complete this short survey (forms.office.com/e/sA3Mzeev3D), which seeks to gain an overview of opinions from UK-based healthcare professionals in relation to cardio-oncology research priorities.

The PROACT trial found adding enalapril to standard care during chemotherapy did not prevent cardiotoxicity in patients receiving high-dose anthracycline-based chemotherapy. Read more on the trial: bit.ly/3ZnZWiV #ACCLATAM

We are highlighting the sessions you can expect at BSEcho 2024 - we're excited to see you in Edinburgh! See the programme for our cardio-oncology session in association with @BCOSCardioOnc 👇 View the full programme and book on our website: ow.ly/PFpC50SZ6rA

This joint @BritishCardioSo @BCOSCardioOnc and @UCLH Cancer Academy course will give the attendee an update in contemporary cardio-oncology practice and will cover recent updates in cardio-oncology. …s.britishcardiovascularsociety.org.uk/events/668d45d…

#GCOS2024 is going to be packed with talks from leading voices around the world including @BlaesAnneMD, Dr Alexander Lyon, Dr Bonnie Ky, and many more. See the Full Lineup: gcos2024.com/agenda Don't miss out - save your spot: gcos2024.com/registration #cardioonc

In this #JACCCardioOnc review, Dr. @DavidGGent, et al cover the breadth of what is known about #CVD in the adult #HCT population, focusing on acute & late complications, risk prediction, surveillance, & treatment of complications. bit.ly/3ZeW97w #CardioOnc

Food for thought. Are the historical anthracycline conversion ratios still appropriate for use in contemporary clinical practice and research? jamanetwork.com/journals/jamao…

SCE (HF, cardiogenic shock or MI) in 16% & ☠️ in 53% at last f/u. SCE associated w/ ⬆️ overall mortality (HR 2.8; 95% CI 1.6 - 4.7) and non-relapse mortality (HR 3.5; 95% CI 1.4 - 8.8). ☠️ associated w/ ⬆️ IL-6 and ferritin after CAR-T, SCE also associated w/ ⬆️ CRP & trop.

10. Biomarkers and cardiovascular outcomes in CAR T-cell therapy recipients ❓Multi-centre registry study examining the association between CAR-T related severe CV events (SCE) and mortality. 🏥202 patients w/ anti-CD19 CAR-T, median f/u 297 days. academic.oup.com/eurheartj/arti…

A selection of the 10 best cardio-oncology papers this year (in no particular order...)🎁🎄🎅 @CircAHA @escardio @ehj_ed @JACCJournals @NatureMedicine @JAMA_current @ICOSociety @CD_AACR @ACPUK @BritSocHaem @TheBHF